We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
<sup>64</sup>Cu-ATSM and <sup>99m</sup>Tc(CO)<sub>3</sub>-DCM20 potential in the early detection of rheumatoid arthritis.
- Authors
Trang Thuy Dam; Hirofumi Hanaoka; Takahito Nakajima; Aiko Yamaguchi; Koichi Okamura; Hirotaka Chikuda; Yoshito Tsushima
- Abstract
Objectives: Molecular imaging constitutes a promising technique for the early detection of rheumatoid arthritis (RA). Macrophages and hypoxia play significant roles in inflamed synovium. In the present study, we evaluated the efficacy of radiopharmaceuticals that target macrophage mannose receptors (99mTc-labeled mannosylated dextran or 99mTc(CO)3-DCM20) and hypoxia (copper(II) diacetyl-di(N4-methylthiosemicarbazone) or Cu-ATSM) for the early detection of RA in collagen-induced arthritis (CIA) mice models. Methods: CIA model was developed in DBA/1 mice, and the clinical score for arthritis was visually assessed on a regular basis. Two biodistribution studies were performed in a paired-labeled format using 2-deoxy-2-F-fluoro-D-glucose (18F-FDG) as a reference: (1) 99mTc(CO)3-DCM20 with 18F-FDG and (2) 67Cu-ATSM with 18F-FDG. Results: The accumulation levels of 99mTc(CO)3-DCM20 and 67Cu-ATSM in forepaws, hindpaws, and knee joints of CIA mice were significantly higher than that of control mice. In contrast, 18F-FDG uptake in hindpaws and knee joints showed no significant difference between CIA and control mice. The radioactivity levels of 99mTc(CO)3-DCM20 and 67Cu-ATSM were significantly correlated with the clinical scores for the paws. Conclusion: These results suggest the potential usefulness of 99mTc(CO)3-DCM20 and radiolabeled Cu-ATSM for the imaging and early detection of RA.
- Subjects
RHEUMATOID arthritis diagnosis; MACROPHAGES; HYPOXEMIA; RADIOPHARMACEUTICALS; MANNOSE; DEXTRAN; ANIMAL models of arthritis
- Publication
Modern Rheumatology, 2021, Vol 31, Issue 2, p350
- ISSN
1439-7595
- Publication type
Article
- DOI
10.1080/14397595.2020.1751945